From October 1, 2016 to December 31, 2016, the company has repurchased 1,684,556 shares, representing 1.21% for $149.99 million. With this, the company has completed the repurchase of 50,944,247 shares, representing 32.71% for $3,121.36 million under the buyback announced on October 20, 2010.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,507 GBX | +0.38% |
|
+0.03% | +3.81% |
10:20am | EU court criticizes Commission over handling of COVID vaccine contracts | RE |
16/07 | Emma Walmsley, CEO of GSK: Antimicrobial resistance, a public health issue | MT |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+3.81% | 79.3B | |
+61.53% | 848B | |
+33.05% | 627B | |
-3.66% | 363B | |
+15.06% | 318B | |
+9.18% | 299B | |
+13.58% | 243B | |
+16.20% | 225B | |
+15.67% | 179B | |
+2.47% | 167B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Tranche Update on Quest Diagnostics Incorporated's Equity Buyback Plan announced on October 20, 2010.